Travere Therapeutics
TVTX
#3235
Rank
โ‚ฌ4.22 B
Marketcap
43,98ย โ‚ฌ
Share price
-3.86%
Change (1 day)
41.49%
Change (1 year)

EPS for Travere Therapeutics (TVTX)

EPS in 2026 (TTM): -1,13ย โ‚ฌ

According to Travere Therapeutics's latest financial reports the company's current EPS (TTM) is -1,17ย โ‚ฌ. In 2025 the company made an earnings per share (EPS) of -0,26ย โ‚ฌ an increase over its 2024 EPS that were of -3,73ย โ‚ฌ.

EPS history for Travere Therapeutics from 2015 to 2026

Annual EPS

Year EPS Change
2026 (TTM)-1,13ย โ‚ฌ327.83%
2025-0,26ย โ‚ฌ-92.93%
2024-3,73ย โ‚ฌ154.66%
2023-1,47ย โ‚ฌ-63.16%
2022-3,98ย โ‚ฌ44.22%
2021-2,76ย โ‚ฌ-10.09%
2020-3,07ย โ‚ฌ
2018-2,31ย โ‚ฌ64.94%
2017-1,40ย โ‚ฌ
20153,29ย โ‚ฌ

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
OPKO Health
OPK
-0,17ย โ‚ฌ-85.27%๐Ÿ‡บ๐Ÿ‡ธ USA
Onconova Therapeutics
ONTX
-0,87ย โ‚ฌ-26.36%๐Ÿ‡บ๐Ÿ‡ธ USA